| Trial ID: | L6083 |
| Source ID: | NCT04833413
|
| Associated Drug: |
Continuous Intensive Insulin Therapy
|
| Title: |
Regimen Switch After Intensive Insulin Therapy
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Insulin
|
| Interventions: |
DRUG: Continuous intensive insulin therapy
|
| Outcome Measures: |
Primary: Change in HbA1c, HbA1c in different conversion regimens, 1，3，6 months | Secondary: The average blood glucose, The average blood glucose in different conversion regimens, 1，3，6 months|Fasting blood glucose, Fasting blood glucose in different conversion regimens, 1，3，6 months|Postprandial blood glucose, Postprandial blood glucose in different conversion regimens, 1，3，6 months|Incidence of hypoglycemia, Incidence of hypoglycemia in different conversion regimens, 1，3，6 months|Impact on body weight, Impact on body weight in different conversion regimens, 1，3，6 months
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Zhongshan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1000
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2021-04-15
|
| Completion Date: |
2024-05-31
|
| Results First Posted: |
|
| Last Update Posted: |
2023-06-07
|
| Locations: |
Zhongshan hospital, Shanghai, Shanghai, 200032, China|Department of Endocrinoogy, Zhongshan Hospital Fudan University, Shanghai, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04833413
|
